NCT00995618已完成2 期
A Randomized, Double-Blind, Crossover, Pharmacodynamic and Pharmacokinetic Drug Interaction Study of Tranilast in Combination With Febuxostat Compared With Tranilast Alone and Febuxostat Alone in Healthy Subjects With Hyperuricemia
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 24
- 试验地点
- 1
- 主要终点
- Mean decrease in serum uric acid levels
研究概览
简要总结
This is a randomized, double-blind, 3-period crossover phase 2 study in patients with documented hyperuricemia to evaluate the effect of tranilast on febuxostat pharmacokinetics (PK) and pharmacodynamics (PD) and to evaluate the effect of febuxostat on tranilast PK and PD as measured by reduction in serum uric acid levels.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Investigator)
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female, aged 18 to 70
- •Subjects with hyperuricemia who are otherwise healthy
排除标准
- •Pregnant or nursing
- •Known history of gout
- •Clinically significant infection at Screening
- •Known sensitivity to tranilast or febuxostat
研究组 & 干预措施
Tranilast
Experimental
Tranilast tablets
干预措施: Tranilast (Drug)
Febuxostat
Active Comparator
Febuxostat tablets
干预措施: Febuxostat (Drug)
Combination
Experimental
Tranilast plus febuxostat
干预措施: Combination - Tranilast and Febuxostat (Drug)
结局指标
主要结局
Mean decrease in serum uric acid levels
时间窗: Seven days
次要结局
- Analysis of pharmacokinetic parameters (AUC, Cmax) of tranilast, febuxostat and combination(7 days)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Study of Tranilast Alone or in Combination With Allopurinol in Subjects With HyperuricemiaGoutHyperuricemiaNCT01052987Nuon Therapeutics, Inc.24
已完成
2 期
AD109 Dose Finding in Mild to Moderate OSAObstructive Sleep ApneaNCT04631107Apnimed32
已完成
3 期
Amifampridine Phosphate for the Treatment of Congenital Myasthenic SyndromesMyasthenic Syndromes, CongenitalNCT02562066Catalyst Pharmaceuticals, Inc.20
已完成
2 期
Crossover Trial of AD036 in Obstructive Sleep ApneaObstructive Sleep ApneaNCT04445688Apnimed62
已完成
2 期
The Safety and Efficacy of SPD465 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)Attention-Deficit/Hyperactivity DisorderNCT00928148Shire86